gamma-aminobutyric acid has been researched along with Psychoses, Drug in 25 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clinically significant side effects of the new anticonvulsants, such as metabolic acidosis from topiramate, autoimmune reactions from lamotrigine, hyponatremia from oxcarbazepine, or psychosis from levitiracetam can cause serious morbidity and mortality if unrecognized." | 4.86 | Emergent complications of the newer anticonvulsants. ( Dang, CV; Nelson, L; Wade, JF; Wasserberger, J, 2010) |
| "Vigabatrin is among the most promising of the new anti-epilepsy drugs, but two unrelated complications have been noted in patients receiving vigabatrin for chronic refractory epilepsy." | 4.79 | Behavioural abnormalities and retention rates of anti-epilepsy drugs during long-term treatment of epilepsy: a clinical perspective. ( Schmidt, D, 1995) |
| "A 7-year-old boy with intractable epilepsy developed acute psychosis 3 days after initiating a rapid vigabatrin dosage escalation." | 4.79 | Vigabatrin-associated reversible acute psychosis in a child. ( Beltrán Marqués, M; Cánovas Martínez, A; Delgado Cordón, F; Escrivá Aparisi, A; Ordovás Baines, JP, 1995) |
| "The aim of this study is to investigate the effects of pregabalin on the behavior of rats under the influence of ketamine, an NMDA receptor antagonist that mimics the symptoms of schizophrenia." | 3.78 | Effects of pregabalin on behavioral alterations induced by ketamine in rats. ( Baker, GB; Canever, L; Crippa, JA; Dursun, SM; Hallak, JE; Luca, RD; Nunes, EA; Oliveira, Ld; Peregrino, A; Quevedo, J; Zugno, A, 2012) |
| "Current treatments of schizophrenia are compromised by their inability to treat all symptoms of the disease and their side-effects." | 2.44 | Modelling prefrontal cortex deficits in schizophrenia: implications for treatment. ( Cochran, SM; Egerton, A; Morris, BJ; Pratt, JA; Winchester, C, 2008) |
| "Schizophrenia is the most prevalent form of psychosis, but this may also occur due to other medical conditions (e." | 2.40 | GABA-ergic neurons and the neurobiology of schizophrenia and other psychoses. ( Keverne, EB, 1999) |
| "A 7-year-old boy with intractable epilepsy developed acute psychosis 3 days after initiating a rapid vigabatrin dosage escalation." | 2.39 | Vigabatrin-associated reversible acute psychosis in a child. ( Beltrán Marqués, M; Cánovas Martínez, A; Delgado Cordón, F; Escrivá Aparisi, A; Ordovás Baines, JP, 1995) |
| " This may be related to dosage and speed of introduction." | 2.39 | Psychotic and severe behavioural reactions with vigabatrin: a review. ( Ferrie, CD; Panayiotopoulos, CP; Robinson, RO, 1996) |
| "Phencyclidine (PCP) is a major drug of abuse as well as a 'drug of choice' among substance abusers in the U." | 2.37 | [Phencyclidine, a drug which induces psychosis: its neuropharmacological actions]. ( Furukawa, H; Kameyama, T; Nabeshima, T, 1984) |
| "All amphetamine treatments diminished the potassium-stimulated (50 mM) release of preloaded labelled dopamine from superfused striatal and frontal cortical slices in vitro." | 1.28 | Animal models of amphetamine psychosis: neurotransmitter release from rat brain slices. ( Lillrank, SM; Oja, SS; Saransaari, P; Seppälä, T, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (20.00) | 18.7374 |
| 1990's | 6 (24.00) | 18.2507 |
| 2000's | 6 (24.00) | 29.6817 |
| 2010's | 8 (32.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nunes, EA | 1 |
| Canever, L | 1 |
| Oliveira, Ld | 1 |
| Luca, RD | 1 |
| Quevedo, J | 1 |
| Zugno, A | 1 |
| Peregrino, A | 1 |
| Crippa, JA | 1 |
| Dursun, SM | 1 |
| Baker, GB | 1 |
| Hallak, JE | 1 |
| West, S | 1 |
| Kenedi, C | 1 |
| Evrensel, A | 1 |
| Ünsalver, BÖ | 1 |
| Rubino, T | 1 |
| Parolaro, D | 1 |
| Zhang, K | 1 |
| Zhao, Y | 1 |
| Wang, Q | 1 |
| Jiang, H | 1 |
| Du, J | 1 |
| Yu, S | 1 |
| Zhao, M | 1 |
| Wade, JF | 1 |
| Dang, CV | 1 |
| Nelson, L | 1 |
| Wasserberger, J | 1 |
| Rutten, BP | 1 |
| Mill, J | 1 |
| Wierońska, JM | 1 |
| Kusek, M | 1 |
| Tokarski, K | 1 |
| Wabno, J | 1 |
| Froestl, W | 1 |
| Pilc, A | 1 |
| Pedroso, JL | 1 |
| Nakama, GY | 1 |
| Carneiro Filho, M | 1 |
| Barsottini, OG | 1 |
| Jablonowski, K | 1 |
| Margolese, HC | 1 |
| Chouinard, G | 1 |
| D'Souza, DC | 1 |
| Gil, RB | 1 |
| Zuzarte, E | 1 |
| MacDougall, LM | 1 |
| Donahue, L | 1 |
| Ebersole, JS | 1 |
| Boutros, NN | 1 |
| Cooper, T | 1 |
| Seibyl, J | 1 |
| Krystal, JH | 1 |
| Olaizola, I | 1 |
| Ellger, T | 1 |
| Young, P | 1 |
| Bösebeck, F | 1 |
| Evers, S | 1 |
| Kellinghaus, C | 1 |
| Pratt, JA | 1 |
| Winchester, C | 1 |
| Egerton, A | 1 |
| Cochran, SM | 1 |
| Morris, BJ | 1 |
| Meldrum, B | 1 |
| Nabeshima, T | 1 |
| Furukawa, H | 1 |
| Kameyama, T | 1 |
| Gerlach, J | 1 |
| Bjørndal, N | 1 |
| Christensson, E | 1 |
| Schmidt, D | 1 |
| Jawad, S | 1 |
| Clarke, E | 1 |
| Richens, A | 1 |
| Cánovas Martínez, A | 1 |
| Ordovás Baines, JP | 1 |
| Beltrán Marqués, M | 1 |
| Escrivá Aparisi, A | 1 |
| Delgado Cordón, F | 1 |
| Ferrie, CD | 1 |
| Robinson, RO | 1 |
| Panayiotopoulos, CP | 1 |
| Keverne, EB | 1 |
| Lindenmayer, JP | 1 |
| Ackenheil, M | 1 |
| Hippius, H | 1 |
| Matussek, N | 1 |
| Luchins, D | 1 |
| Lillrank, SM | 1 |
| Oja, SS | 1 |
| Saransaari, P | 1 |
| Seppälä, T | 1 |
12 reviews available for gamma-aminobutyric acid and Psychoses, Drug
| Article | Year |
|---|---|
Strategies to prevent the neuropsychiatric side-effects of corticosteroids: a case report and review of the literature.
Topics: Adult; Amines; Benzodiazepines; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Female; Gaba | 2014 |
The Impact of Exposure to Cannabinoids in Adolescence: Insights From Animal Models.
Topics: Adolescent; Animals; Brain; Cannabinoids; Cognition; Disease Models, Animal; Endocannabinoids; gamma | 2016 |
Emergent complications of the newer anticonvulsants.
Topics: Acidosis; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Overdose; Fructo | 2010 |
Epigenetic mediation of environmental influences in major psychotic disorders.
Topics: Alleles; Bipolar Disorder; Child; Child Abuse; Diseases in Twins; DNA Methylation; Epigenesis, Genet | 2009 |
Modelling prefrontal cortex deficits in schizophrenia: implications for treatment.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Excitatory Amino Acid Antagonists; gamma-Amin | 2008 |
GABA and acute psychoses.
Topics: Acute Disease; Animals; Brain; Cats; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Humans; Limbi | 1982 |
[Phencyclidine, a drug which induces psychosis: its neuropharmacological actions].
Topics: Acetylcholine; Animals; Behavior, Animal; Binding Sites; Brain; Cats; Dogs; Dopamine; Drug Tolerance | 1984 |
Behavioural abnormalities and retention rates of anti-epilepsy drugs during long-term treatment of epilepsy: a clinical perspective.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Epilepsy | 1995 |
Vigabatrin-associated reversible acute psychosis in a child.
Topics: 4-Aminobutyrate Transaminase; Acute Disease; Anticonvulsants; Child; Clinical Trials as Topic; Enzym | 1995 |
Psychotic and severe behavioural reactions with vigabatrin: a review.
Topics: Adult; Anticonvulsants; Child; Contraindications; Dose-Response Relationship, Drug; Epilepsy; Epilep | 1996 |
GABA-ergic neurons and the neurobiology of schizophrenia and other psychoses.
Topics: Animals; Cerebral Cortex; gamma-Aminobutyric Acid; Humans; Interneurons; Psychoses, Substance-Induce | 1999 |
The pathophysiology of agitation.
Topics: Aggression; Behavioral Symptoms; Bipolar Disorder; Dementia; Dopamine; gamma-Aminobutyric Acid; Huma | 2000 |
1 trial available for gamma-aminobutyric acid and Psychoses, Drug
| Article | Year |
|---|---|
gamma-Aminobutyric acid-serotonin interactions in healthy men: implications for network models of psychosis and dissociation.
Topics: Analysis of Variance; Anxiety; Cross-Over Studies; Dissociative Disorders; Double-Blind Method; Drug | 2006 |
12 other studies available for gamma-aminobutyric acid and Psychoses, Drug
| Article | Year |
|---|---|
Effects of pregabalin on behavioral alterations induced by ketamine in rats.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, | 2012 |
Psychotic and depressive symptoms after gabapentin treatment.
Topics: Amines; Cyclohexanecarboxylic Acids; Depression; Excitatory Amino Acid Antagonists; Female; Gabapent | 2015 |
Association study of GABA system genes polymorphisms with amphetamine-induced psychotic disorder in a Han Chinese population.
Topics: Adult; Amphetamine; Asian People; Case-Control Studies; Female; gamma-Aminobutyric Acid; Gene Freque | 2016 |
The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.
Topics: Animals; Behavior, Animal; Catalepsy; Cyclopentanes; Disease Models, Animal; Dose-Response Relations | 2011 |
Delirium, psychosis, and visual hallucinations induced by pregabalin.
Topics: Adult; Analgesics; Delirium; Female; gamma-Aminobutyric Acid; Hallucinations; Humans; Low Back Pain; | 2012 |
Gabapentin-induced paradoxical exacerbation of psychosis in a patient with schizophrenia.
Topics: Acetates; Adult; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyri | 2002 |
Pregabalin-associated acute psychosis and epileptiform EEG-changes.
Topics: Acute Disease; Adult; Anticonvulsants; Dose-Response Relationship, Drug; Electroencephalography; Fem | 2006 |
Methylphenidate, apomorphine, THIP, and diazepam in monkeys: dopamine-GABA behavior related to psychoses and tardive dyskinesia.
Topics: Animals; Apomorphine; Chlorocebus aethiops; Diazepam; Dopamine; Drug Interactions; Dyskinesia, Drug- | 1984 |
Vigabatrin-induced psychosis--management problems.
Topics: Adult; Brain Damage, Chronic; Carbamazepine; Female; gamma-Aminobutyric Acid; Humans; Psychoses, Sub | 1994 |
[Findings of biochemical research on schizophrenia (author's transl)].
Topics: 5-Methoxytryptamine; Antipsychotic Agents; Brain; Dopamine; gamma-Aminobutyric Acid; Humans; Lysergi | 1978 |
The dopamine hypothesis of schizophrenia. A critical analysis.
Topics: Acetylcholine; Amphetamine; Apomorphine; Cocaine; Dopamine; Electroconvulsive Therapy; gamma-Aminobu | 1975 |
Animal models of amphetamine psychosis: neurotransmitter release from rat brain slices.
Topics: Amino Acids; Amphetamine; Animals; Aspartic Acid; Behavior, Animal; Brain; Cerebral Cortex; Corpus S | 1991 |